Citicoline Suppliers & Bulk Manufacturers
Available Forms: White to off-white crystalline powder
Available Strengths: API Purity: ≥ 98% (on dry basis) / Standard content expressed as Citicoline equivalent
Reference Brands:
Category:
Active Pharmaceutical Ingredient
Citicoline is a medicine with neuroprotective effects (protects the nerve). Hence, It is used in the treatment of brain stroke (damage to your brain due to improper blood supply), memory loss, and movement disorders associated with ageing.
Citicoline is available in White to off-white crystalline powder
and strengths such as API Purity: ≥ 98% (on dry basis) / Standard content expressed as Citicoline equivalent.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Citicoline is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Citicoline can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Citicoline (CDP-Choline) is a nootropic compound and an intermediate in the generation of phosphatidylcholine from choline. It plays a vital role in brain health by promoting the synthesis of phospholipids, which are essential components of cell membranes. Widely used in pharmaceuticals and nutraceuticals, Citicoline is indicated for neurological disorders such as stroke recovery, memory impairment, and cognitive decline. The API is highly stable, water-soluble, and suitable for formulation into tablets, capsules, and injectables.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing